TY - JOUR
T1 - Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition
AU - Kücükdisli, Murat
AU - Bel-Abed, Hassen
AU - Cirillo, Davide
AU - Lo, Wen Ting
AU - Efrém, Nina Louisa
AU - Horatscheck, André
AU - Perepelittchenko, Liudmila
AU - Prokofeva, Polina
AU - Ehret, Theresa A.L.
AU - Radetzki, Silke
AU - Neuenschwander, Martin
AU - Specker, Edgar
AU - Médard, Guillaume
AU - Müller, Susanne
AU - Wilhelm, Stephanie
AU - Kuster, Bernhard
AU - Von Kries, Jens Peter
AU - Haucke, Volker
AU - Nazaré, Marc
N1 - Publisher Copyright:
© 2023 American Chemical Society. All rights reserved.
PY - 2023/10/26
Y1 - 2023/10/26
N2 - Class II phosphoinositide-3-kinases (PI3Ks) play central roles in cell signaling, division, migration, and survival. Despite evidence that all PI3K class II isoforms serve unique cellular functions, the lack of isoform-selective inhibitors severely hampers the systematic investigation of their potential relevance as pharmacological targets. Here, we report the structural evaluation and molecular determinants for selective PI3K-C2α inhibition by a structure-activity relationship study based on a pteridinone scaffold, leading to the discovery of selective PI3K-C2α inhibitors called PITCOINs. Cocrystal structures and docking experiments supported the rationalization of the structural determinants essential for inhibitor activity and high selectivity. Profiling of PITCOINs in a panel of more than 118 diverse kinases showed no off-target kinase inhibition. Notably, by addressing a selectivity pocket, PITCOIN4 showed nanomolar inhibition of PI3K-C2α and >100-fold selectivity in a general kinase panel. Our study paves the way for the development of novel therapies for diseases related to PI3K-C2α function.
AB - Class II phosphoinositide-3-kinases (PI3Ks) play central roles in cell signaling, division, migration, and survival. Despite evidence that all PI3K class II isoforms serve unique cellular functions, the lack of isoform-selective inhibitors severely hampers the systematic investigation of their potential relevance as pharmacological targets. Here, we report the structural evaluation and molecular determinants for selective PI3K-C2α inhibition by a structure-activity relationship study based on a pteridinone scaffold, leading to the discovery of selective PI3K-C2α inhibitors called PITCOINs. Cocrystal structures and docking experiments supported the rationalization of the structural determinants essential for inhibitor activity and high selectivity. Profiling of PITCOINs in a panel of more than 118 diverse kinases showed no off-target kinase inhibition. Notably, by addressing a selectivity pocket, PITCOIN4 showed nanomolar inhibition of PI3K-C2α and >100-fold selectivity in a general kinase panel. Our study paves the way for the development of novel therapies for diseases related to PI3K-C2α function.
UR - http://www.scopus.com/inward/record.url?scp=85175270365&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.3c01319
DO - 10.1021/acs.jmedchem.3c01319
M3 - Article
C2 - 37819647
AN - SCOPUS:85175270365
SN - 0022-2623
VL - 66
SP - 14278
EP - 14302
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 20
ER -